Global and United States CRM197 Market Report & Forecast 2022-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,350	75 Pages	QYResearch Group	March, 2022	QYR17049136

Best Price Guarantee
Price	from $4,350
Length	75 Pages
Publisher	QYResearch Group
Published Date	March, 2022
SKU	QYR17049136

Global and United States CRM197 Market Report & Forecast 2022-2028

Summary

Market Analysis and Insights: Global and United States CRM197 Market
This report focuses on global and United States CRM197 market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global CRM197 market size is estimated to be worth US$ 177.06 million in 2022 and is forecast to a readjusted size of US$ 240.83 million by 2028 with a CAGR of 5.26% during the review period. Fully considering the economic change by this health crisis, Research Grade accounting for 12.18% of the CRM197 global market in 2021, is projected to value US$ 29.13 million by 2028, growing at a revised 5.16% CAGR in the post-COVID-19 period. While Pneumococcal Conjugate Vaccine was the leading segment, accounting for over 89.19 percent market share in 2021, and altered to an 5.29 % CAGR throughout this forecast period.
In United States the CRM197 market size is expected to grow from US$ 124.12 million in 2021 to US$ 175.23 million by 2028, at a CAGR of 5.58% during the forecast period.
Global CRM197 Scope and Market Size
CRM197 market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global CRM197 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the CRM197 market size by players, by Type, and by Application, for the period 2017-2028. The key players include the global and local players which play important roles in United States.

By Company
Pfizer Inc.
Fina Biosolutions
Eubiologics
EirGenix Inc.
Xpress Biologics
Ligand Pharmaceuticals
Scarab Genomics
CanSino Biologic
Beijing Kexing Biology Product

Segment by Type
Research Grade
CGMP Grade

Segment by Application
Pneumococcal Conjugate Vaccine
Meningococcal Polysaccharide Conjugate Vaccine
Others

By Region
North America
United States
Canada

Asia-Pacific
China
Japan
South Korea
India

Europe
Germany
France
U.K.
Italy
Russia

1 STUDY COVERAGE: 1.1 CRM197 Product Introduction; 1.2 Global CRM197 Outlook, 2017 VS 2022 VS 2028; 1.2.1 Global CRM197 Market Size for the Year 2017-2028; 1.2.2 United States CRM197 Market Size for the Year 2017-2028; 1.3 CRM197 Market Size, United States VS Global, 2017 VS 2022 VS 2028; 1.3.1 The Market Size of United States CRM197 in Global, 2017 VS 2022 VS 2028; 1.3.2 The Growth Rate of CRM197 Market Size, United States VS Global, 2017 VS 2022 VS 2028; 1.4 CRM197 Market Dynamics; 1.4.1 CRM197 Industry Trends; 1.4.2 CRM197 Market Drivers; 1.4.3 CRM197 Market Challenges; 1.4.4 CRM197 Market Restraints; 1.5 Study Objectives; 1.6 Years Considered
2 CRM197 BY TYPE: 2.1 CRM197 Market Segment by Type; 2.1.1 Research Grade; 2.1.2 CGMP Grade; 2.2 Global CRM197 Market Size by Type (2017, 2022 & 2028); 2.3 Global CRM197 Market Size by Type (2017-2028); 2.4 United States CRM197 Market Size by Type (2017, 2022 & 2028); 2.5 United States CRM197 Market Size by Type (2017-2028)
3 CRM197 BY APPLICATION: 3.1 CRM197 Market Segment by Application; 3.1.1 Pneumococcal Conjugate Vaccine; 3.1.2 Meningococcal Polysaccharide Conjugate Vaccine; 3.1.3 Others; 3.2 Global CRM197 Market Size, by Application (2017, 2022 & 2028); 3.3 Global CRM197 Market Size by Application (2017-2028); 3.4 United States CRM197 Market Size by Application (2017, 2022 & 2028); 3.5 United States CRM197 Market Size by Application (2017-2028)
4 GLOBAL CRM197 COMPETITOR LANDSCAPE BY COMPANY: 4.1 Global CRM197 Market Size by Company; 4.1.1 Top Global CRM197 Companies Ranked by Revenue (2021); 4.1.2 Global CRM197 Revenue by Player (2017-2022); 4.2 Global CRM197 Concentration Ratio (CR); 4.2.1 CRM197 Market Concentration Ratio (CR) (2017-2022); 4.2.2 Global Top 3 Largest Companies of CRM197 in 2021; 4.2.3 Global CRM197 Market Share by Company Type (Tier 1, Tier 2, and Tier 3); 4.3 Global CRM197 Headquarters, Product Type; 4.3.1 Global CRM197 Headquarters and Area Served; 4.3.2 Global CRM197 Companies Product Type; 4.3.3 Date of International Companies Establish; 4.4 Companies Mergers & Acquisitions, Expansion Plans; 4.5 United States CRM197 Market Size by Company; 4.5.1 Top CRM197 Players in United States, Ranked by Revenue (2021); 4.5.2 United States CRM197 Revenue by Players (2020, 2021 & 2022)
5 GLOBAL CRM197 MARKET SIZE BY REGION: 5.1 Global CRM197 Market Size by Region: 2017 VS 2022 VS 2028; 5.2 Global CRM197 Market Size by Region (2017-2028); 5.2.1 Global CRM197 Market Size by Region: 2017-2022; 5.2.2 Global CRM197 Market Size by Region: 2023-2028
6 SEGMENT IN REGIONAL LEVEL & COUNTRY LEVEL: 6.1 North America; 6.1.1 North America CRM197 Market Size YoY Growth 2017-2028; 6.1.2 North America CRM197 Market Facts & Figures by Country (2017, 2022 & 2028); 6.1.3 United States; 6.1.4 Canada; 6.2 Asia-Pacific; 6.2.1 Asia-Pacific CRM197 Market Size YoY Growth 2017-2028; 6.2.2 Asia-Pacific CRM197 Market Facts & Figures by Region (2017, 2022 & 2028); 6.2.3 China; 6.2.4 Japan; 6.2.5 South Korea; 6.2.6 India; 6.3 Europe; 6.3.1 Europe CRM197 Market Size YoY Growth 2017-2028; 6.3.2 Europe CRM197 Market Facts & Figures by Country (2017, 2022 & 2028); 6.3.3 Germany; 6.3.4 U.K.; 6.3.5 France; 6.3.6 Italy; 6.3.7 Russia
7 KEY PLAYERS PROFILES: 7.1 Pfizer Inc.; 7.1.1 Pfizer Inc. Company Details; 7.1.2 Pfizer Inc. Business Overview; 7.1.3 Pfizer Inc. CRM197 Introduction; 7.1.4 Pfizer Inc. Revenue in CRM197 Business (2017-2022); 7.1.5 Pfizer Inc. Recent Development; 7.2 Ligand Pharmaceuticals; 7.2.1 Ligand Pharmaceuticals Company Details; 7.2.2 Ligand Pharmaceuticals Business Overview; 7.2.3 Ligand Pharmaceuticals CRM197 Introduction; 7.2.4 Ligand Pharmaceuticals Revenue in CRM197 Business (2017-2022); 7.2.5 Ligand Pharmaceuticals Recent Development; 7.3 CanSino Biologic; 7.3.1 CanSino Biologic Company Details; 7.3.2 CanSino Biologic Business Overview; 7.3.3 CanSino Biologic CRM197 Introduction; 7.3.4 CanSino Biologic Revenue in CRM197 Business (2017-2022); 7.3.5 CanSino Biologic Recent Development; 7.4 Beijing Kexing Biology Product; 7.4.1 Beijing Kexing Biology Product Company Details; 7.4.2 Beijing Kexing Biology Product Business Overview; 7.4.3 Beijing Kexing Biology Product CRM197 Introduction; 7.4.4 Beijing Kexing Biology Product Revenue in CRM197 Business (2017-2022); 7.5 Scarab Genomics; 7.5.1 Scarab Genomics Company Details; 7.5.2 Scarab Genomics Business Overview; 7.5.3 Scarab Genomics CRM197 Introduction; 7.5.4 Scarab Genomics Revenue in CRM197 Business (2017-2022); 7.6 Xpress Biologics; 7.6.1 Xpress Biologics Company Details; 7.6.2 Xpress Biologics Business Overview; 7.6.3 Xpress Biologics CRM197 Introduction; 7.6.4 Xpress Biologics Revenue in CRM197 Business (2017-2022); 7.7 Fina Biosolutions; 7.7.1 Fina Biosolutions Company Details; 7.7.2 Fina Biosolutions Business Overview; 7.7.3 Fina Biosolutions CRM197 Introduction; 7.7.4 Fina Biosolutions Revenue in CRM197 Business (2017-2022); 7.8 Eubiologics; 7.8.1 Eubiologics Company Details; 7.8.2 Eubiologics Business Overview; 7.8.3 Eubiologics CRM197 Introduction; 7.8.4 Eubiologics Revenue in CRM197 Business (2017-2022); 7.8.5 Eubiologics Recent Development; 7.9 EirGenix Inc.; 7.9.1 EirGenix Inc. Company Details; 7.9.2 EirGenix Inc. Business Overview; 7.9.3 EirGenix Inc. CRM197 Introduction; 7.9.4 EirGenix Inc. Revenue in CRM197 Business (2017-2022); 7.9.5 EirGenix Inc. Recent Development
8 RESEARCH FINDINGS AND CONCLUSION
9 APPENDIX: 9.1 Research Methodology; 9.1.1 Methodology/Research Approach; 9.1.2 Data Source; 9.2 Disclaimer; 9.3 Author Details
List of Tables: Table 1. CRM197 Market Size, United States VS Global, CAGR (2017 VS 2022 VS 2028); Table 2. CRM197 Market Trends; Table 3. CRM197 Market Drivers; Table 4. CRM197 Market Challenges; Table 5. CRM197 Market Restraints; Table 6. Global CRM197 Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million); Table 7. United States CRM197 Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million); Table 8. Global CRM197 Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million); Table 9. United States CRM197 Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million); Table 10. Top CRM197 Companies in Global Market, Ranking by Revenue (2021); Table 11. Global CRM197 Revenue by Player, (US$ Million), 2017-2022; Table 12. Global CRM197 Revenue Share by Player, 2017-2022; Table 13. Global CRM197 Companies Market Concentration Ratio (CR5 and HHI); Table 14. Global CRM197 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRM197 as of 2021); Table 15. Top Players of CRM197 in Global Market, Headquarters and Area Served; Table 16. Global CRM197 Companies Product Type; Table 17. Date of International Companies Establish; Table 18. Companies Mergers & Acquisitions, Expansion Plans; Table 19. Top CRM197 Players in United States Market, Ranking by Revenue (2021); Table 20. United States CRM197 Revenue by Players, (US$ Million), 2020, 2021 & 2022; Table 21. United States CRM197 Revenue Share by Players, 2020, 2021 & 2022; Table 22. Global CRM197 Market Size by Region (US$ Million): 2017 VS 2022 VS 2028; Table 23. Global CRM197 Market Size by Region (2017-2022) & (US$ Million); Table 24. Global CRM197 Market Size Forecast by Region (2023-2028) & (US$ Million); Table 25. North America CRM197 Market Size by Country (2017-2022) & (US$ Million); Table 26. North America CRM197 Market Size by Country (2023-2028) & (US$ Million); Table 27. Asia-Pacific CRM197 Market Size by Region (2017-2022) & (US$ Million); Table 28. Asia-Pacific CRM197 Market Size by Region (2023-2028) & (US$ Million); Table 29. Europe CRM197 Market Size by Country (2017-2022) & (US$ Million); Table 30. Europe CRM197 Market Size by Country (2023-2028) & (US$ Million); Table 31. Pfizer Inc. Company Details; Table 32. Pfizer Inc. Business Overview; Table 33. Pfizer Inc. CRM197 Product; Table 34. Pfizer Inc. Revenue in CRM197 Business (2017-2022) & (US$ Million); Table 35. Pfizer Inc. Recent Development; Table 36. Ligand Pharmaceuticals Company Details; Table 37. Ligand Pharmaceuticals Business Overview; Table 38. Ligand Pharmaceuticals CRM197 Product; Table 39. Ligand Pharmaceuticals Revenue in CRM197 Business (2017-2022) & (US$ Million); Table 40. Ligand Pharmaceuticals Recent Development; Table 41. CanSino Biologic Company Details; Table 42. CanSino Biologic Business Overview; Table 43. CanSino Biologic CRM197 Product; Table 44. CanSino Biologic Revenue in CRM197 Business (2017-2022) & (US$ Million); Table 45. CanSino Biologic Recent Development; Table 46. Beijing Kexing Biology Product Company Details; Table 47. Beijing Kexing Biology Product Business Overview; Table 48. Beijing Kexing Biology Product CRM197 Product; Table 49. Beijing Kexing Biology Product Revenue in CRM197 Business (2017-2022) & (US$ Million); Table 50. Scarab Genomics Company Details; Table 51. Scarab Genomics Business Overview; Table 52. Scarab Genomics CRM197 Product; Table 53. Scarab Genomics Revenue in CRM197 Business (2017-2022) & (US$ Million); Table 54. Xpress Biologics Company Details; Table 55. Xpress Biologics Business Overview; Table 56. Xpress Biologics CRM197 Product; Table 57. Xpress Biologics Revenue in CRM197 Business (2017-2022) & (US$ Million); Table 58. Fina Biosolutions Company Details; Table 59. Fina Biosolutions Business Overview; Table 60. Fina Biosolutions CRM197 Product; Table 61. Fina Biosolutions Revenue in CRM197 Business (2017-2022) & (US$ Million); Table 62. Eubiologics Company Details; Table 63. Eubiologics Business Overview; Table 64. Eubiologics CRM197 Product; Table 65. Eubiologics Revenue in CRM197 Business (2017-2022) & (US$ Million); Table 66. Eubiologics Recent Development; Table 67. EirGenix Inc. Company Details53